Are we ready for mutational directed treatment: addressing the genomic basis of myeloma
Gareth Morgan et al.
Insights into the genomics of multiple myeloma - new drug targets and when to do a genomic analysis
Discussion of the two biologies of DLBCL - the GCB and ABC subtype and potential targeted therapies
Developments in prognostic factors of acute myeloid leukemia (AML)
Gert J. Ossenkoppele
Waldenstrom macroglobulinemia: Treatment methods and clonal evolution